Portfolio Lab

Ensign Group, Inc

  • Stock
  • Ticker ENSG
  • ISIN US29358P1012
  • Nasdaq

Health care · Health care services · USA

$176.32 −0.15%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Ensign Group, Inc since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

ENSGGlobal equities (VT)

$10,000 grew to $89,924. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −55.6% in 03/2020, measured from the peak in 07/2019. It took 12 months to get back to the old peak.

1-year return
−1.5%
5-year return p.a.
+17.3%
10-year return p.a.
+24.6%
Volatility p.a.
30.2%
Largest decline
−55.6%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue1,1321,1731,2281,2961,3611,3891,4401,484
Gross profit235245256252286293306317
Operating income10110110496124125123138
EBITDA123126130123152154154171
Net income8080848495100100104
Earnings per share1.361.371.441.421.611.671.681.76
Balance sheet
Total assets4,6694,7604,9305,2265,4635,6125,7495,998
Liabilities2,8292,8302,9093,1043,2283,2423,3043,435
Equity1,8371,9272,0182,1192,2322,3662,4422,559
Cash465283364444504539262338
Long-term debt142141140139138136136195
Cash flow
Operating cash flow10072156153183100172240
Free cash flow10072156153183100172240

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2018 at +75.7%, weakest 2017 at +0.8%. 9 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
27 Oct 2026$1.76
27 Jul 2026$1.68
30 Apr 2026$1.67
4 Feb 2026$1.61
3 Nov 2025$1.42
24 Jul 2025$1.44
29 Apr 2025$1.37
5 Feb 2025$1.36
24 Oct 2024$1.34
25 Jul 2024$1.22
1 May 2024$1.19
1 Feb 2024$0.37

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€9.3bn
Market cap in trading currency
$10.3bn
Enterprise value
$10.1bn
P/E
26.2
P/S
1.81
P/B
4.02
EV/Sales
1.78
EV/EBITDA
16.0
Earnings yield
3.8%
FCF yield
6.8%

Results (last four quarters)

Revenue
$5.67bn
Gross profit
$1.20bn
EBITDA
$630m
Net income
$399m
Earnings per share
$6.72
Revenue per share
$97.26
Revenue growth
+14.5%
Earnings growth
+24.4%

Profitability

Gross margin
21.2%
Operating margin
9.0%
Net margin
7.0%
Return on equity
17.1%
Return on assets
6.7%

Balance sheet and cash flow

Cash
$392m
Cash per share
$6.71
Financial debt
$199m
Debt/equity %
8
Current ratio
1.20
Book value per share
$43.87
Operating cash flow
$696m
Free cash flow
$696m

Dividend

Dividend yield
0.15%
Dividend (12 months)
$0.26
Yield (12 months)
0.15%
Payout ratio
4%
Ex-dividend date
30 Sep 2026

Shares and trading

Shares outstanding
58.3m
Volume
252,652
Avg. volume 3 months
356,991
Relative volume
0.7

Price and technicals

Price
$176.32
1 day
−0.2%
52-week high
$215.83
52-week low
$147.13
Distance to 52-week high
−18.3%
Distance to 52-week low
+19.8%
Distance to 50-day line
−0.7%
Distance to 200-day line
−3.2%
RSI (14)
44
Volatility 1M
42.8%

Performance

1 week
−6.4%
1 month
−1.1%
3 months
−1.7%
6 months
+2.5%
YTD
+1.2%
1 year
−1.3%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has ENSG performed since 11/2016?

$10,000 grew to $89,924 by 20 Nov 2026, which is +24.6% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is ENSG?

Volatility was 30.2% per year, measured on monthly returns. The largest decline from a peak was −55.6%, with the low in 03/2020.

How does ENSG compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, ENSG returned +24.6% at 30.2%. The correlation of monthly returns was 0.41; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.